Swedish Orphan Biovitrum AB (publ)
Global biopharma unlocking breakthrough therapies for rare diseases.
Yleiskatsaus
- 200–499
- Työntekijät
- 5–10mrd SEK
- Liikevaihto
- 1972
- Perustettu
Avainpäättäjät
Gerard Tobin
Head of Investor Relations
Helena Saxon
Board member & Chair of the Audit Committee
Iris Loew-Friedrich
Board member
Zlatko Rihter
Board member
+36 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Sobi, or Swedish Orphan Biovitrum AB, is a global biopharmaceutical company dedicated to transforming the everyday lives of people living with rare diseases. The organization focuses intensely on unlocking the potential of breakthrough innovations where the unmet patient need is high. Their core the...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Partihandel med övriga hushållsvaror
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556038932101
- Osoite
- 112 76, STOCKHOLM, SE
Päättäjät
40 yhteystietoa FunnelfeedrissäGerard Tobin
Head of Investor Relations
Helena Saxon
Board member & Chair of the Audit Committee
Iris Loew-Friedrich
Board member
Zlatko Rihter
Board member
Elisabeth Svanberg
Board Member
Daniel Rankin
Head of Strategy & Corporate Development
Norbert Oppitz
Head of International
David Allsop
Board Member
Anders Ullman
Board member
Guido Oelkers
Chief Executive Officer
Christophe Bourdon
Board member
Mats Lek
Board member, employee representative
Lena Bjurner
Head of People & Communication
Christine Wesström
Head of Technical Operations
Theresa Heggie
Board Member
Jeffrey Jonas
Board Member
Susanna Rönnback
Deputy Board Member, Employee Representative and IT Operations Manager Digital Workplace and AI
Mahmood Ladha
Head of Strategic transformation operations
Matthew Gantz
Board Member
David Meek
Chair of the Board
Filippa Stenberg
Board member
Håkan Björklund
Chairman of the Board
Henrik Stenqvist
Chief Financial Officer
Lennart Johansson
Board Member
Katy Mazibuko
Board member, employee representative
Sofiane Fahmy
Head of Europe
Staffan Schüberg
Board member
Geoffrey McDonough
CEO
Annette Clancy
Board Member
Lydia Abad-Franch
Chief Medical Officer, Head of R&D and Medical Affairs
Hans Wigzell
Board Member
Torbjörn Hallberg
General Counsel & Head of Legal Affairs
Sara Carlsson
Deputy Board Member, Employee Representative and Clinical Study Manager
Bo Jesper Hansen
Chairman of the Board
Duane H. Barnes
Head of North America
Adine Grate Axén
Board Member
Hans GCP Shikan
Board Member
Jen Kretzmann
Senior Manager Investor Relations
Muut yhteyshenkilöt
Michael Greksa
Investor Relations North America
Jonatan Hansson
Auditor
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
CSL Behring Aktiebolag
20–49 työntekijätGlobal biotechnology leader developing innovative therapies for rare and serious diseases.
OCTAPHARMA NORDIC AB
5–9 työntekijätDeveloping and manufacturing life-saving plasma-derived therapies globally.
Alvotech Sweden AB
20–49 työntekijätDeveloping and manufacturing affordable biosimilars to expand global medicine access.
Alexion Pharma Nordics AB
10–19 työntekijätPioneering transformative medicines for the global rare disease community.
VIFOR PHARMA NORDISKA AB
Global leader developing innovative therapies for iron deficiency and kidney disease.
Selaa lisää
Kysymyksiä yrityksestä Swedish Orphan Biovitrum AB (publ)
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo